Literature DB >> 8501514

Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: inhibition of truncation in vitro and in vivo.

P S DiStefano1, D M Chelsea, C M Schick, J F McKelvy.   

Abstract

The mechanism of low-affinity NGF receptor (LNGFR) truncation was investigated in cultured Schwann cells. Affinity labeling of Schwann cells with 125I-NGF or metabolic labeling with 35S-cysteine showed that truncated NGF receptor (NGF-Rt) was derived from the cell surface form of the receptor. Addition of full-length, exogenous NGF receptor (M(r) = 80 kDa) to Schwann cell membranes resulted in cleavage of the exogenous substrate to NGF-Rt. Investigations into the mechanism of truncation revealed that metalloprotease inhibitors such as phenanthroline, bathophenanthroline, and 8-hydroxyquinoline (8-OHQ) blocked LNGFR truncation in a concentration-dependent fashion. Inhibitors of other protease classes had no effect on truncation. In addition, truncation did not occur at 4 degrees C. It was found that truncation could also occur in Schwann cell membrane preparations, indicating that the putative protease was membrane bound and closely associated with the LNGFR. Metal reconstitution experiments revealed a strong preference toward zinc for the truncating activity, with iron and manganese having slight reconstitution activity in phenanthroline-quenched membranes. To determine if apparent truncation could be inhibited in vivo, the metalloprotease inhibitor 8-OHQ was administered to neonatal rats. 8-OHQ resulted in decreased urine and blood NGF-Rt levels and increased the sciatic nerve LNGFR content; this effect was dose dependent. In adult rats with sciatic nerve crush lesions, 8-OHQ (30-300 mg/kg, t.i.d.) significantly enhanced the rate of sensory neuron regeneration as assessed by the nerve pinch assay. This was accompanied by increased levels of LNGFR in distal nerve segments. These results suggest that Schwann cells possess a metalloprotease-like activity that serves to cleave LNGFR from the surface of these cells. We propose that the putative metalloprotease represents a novel mechanism by which the Schwann cell regulates this particular cell surface protein. Furthermore, increasing the amount of Schwann cell surface LNGFR appears to be of functional significance in that sensory nerve regeneration can be enhanced by inhibition of truncation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501514      PMCID: PMC6576503     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  11 in total

1.  Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability.

Authors:  Kevin C Kanning; Mark Hudson; Paul S Amieux; Jesse C Wiley; Mark Bothwell; Leslayann C Schecterson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

2.  p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up-regulation of tumor necrosis factor-alpha-converting enzyme/ADAM17.

Authors:  Rajappa S Kenchappa; Chhavy Tep; Zeljka Korade; Soledad Urra; Francisca C Bronfman; Sung Ok Yoon; Bruce D Carter
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

3.  Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.

Authors:  L M Williams; D L Gibbons; A Gearing; R N Maini; M Feldmann; F M Brennan
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells.

Authors:  Peter A Forsyth; Niveditha Krishna; Samuel Lawn; J Gerardo Valadez; Xiaotao Qu; David A Fenstermacher; Michelle Fournier; Lisa Potthast; Prakash Chinnaiyan; Geoffrey T Gibney; Michele Zeinieh; Philip A Barker; Bruce D Carter; Michael K Cooper; Rajappa S Kenchappa
Journal:  J Biol Chem       Date:  2014-02-11       Impact factor: 5.157

5.  Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan.

Authors:  J Zuo; T A Ferguson; Y J Hernandez; W G Stetler-Stevenson; D Muir
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

6.  Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis.

Authors:  A Nishiyama; X H Lin; W B Stallcup
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

7.  Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells.

Authors:  T Yamada; K Miyazaki; N Koshikawa; M Takahashi; H Akatsu; T Yamamoto
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 8.  Molecular mechanisms in Schwann cell survival and death during peripheral nerve development, injury and disease.

Authors:  Kristy Boyle; Michael F Azari; Christos Profyris; Steven Petratos
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.978

9.  Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1.

Authors:  M La Fleur; J L Underwood; D A Rappolee; Z Werb
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment.

Authors:  N Cabrera; E Díaz-Rodríguez; E Becker; D Martín-Zanca; A Pandiella
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.